United Kingdom · Question · Written question
UIN 32905
Armed Forces: Mefloquine
Original
Introduced
24 February 2025
Last action
27 February 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Defence
Source updated
27 February 2025
Summary
To ask the Secretary of State for Defence, what criteria are applied by the Defence Medical Services to distinguish the adverse effects caused by the prescribing of Lariam (Mefloquine) to service personnel as an anti-malarial prophylaxis and those caused
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
24 February 2025
Written question
To ask the Secretary of State for Defence, what criteria are applied by the Defence Medical Services to distinguish the adverse effects caused by the prescribing of Lariam (Mefloquine) to service personnel as an anti-malarial prophylaxis and those caused
Source: Commons
27 February 2025
Answer
People taking mefloquine (also known as Larium) can experience abnormal dreams, symptoms of depression and anxiety, and more rarely psychiatric symptoms such as hallucinations, agitations and psychosis have also been reported. This differs to Post Traumat...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Ministry of Defence · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-02-24/32905
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1777428
- uk · wq-1777428 · source updated 27 February 2025